Securitas Valuation
Is S7MB undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of S7MB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: S7MB (€11.32) is trading below our estimate of fair value (€22.28)
Significantly Below Fair Value: S7MB is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for S7MB?
Key metric: As S7MB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is S7MB's PE Ratio? | |
|---|---|
| PE Ratio | 16.3x |
| Earnings | SEK 4.73b |
| Market Cap | SEK 77.37b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.7x |
| Enterprise Value/EBITDA | 9.6x |
| PEG Ratio | 0.9x |
Price to Earnings Ratio vs Peers
How does S7MB's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 16.8x | ||
GBF Bilfinger | 7.2x | 2.3% | €1.7b |
BFSA Befesa | 13.4x | 29.5% | €740.0m |
CWC CEWE Stiftung KGaA | 11x | 2.5% | €691.2m |
BCO Brink's | 35.6x | 73.6% | US$4.1b |
S7MB Securitas | 16.3x | 18.7% | €77.4b |
Price-To-Earnings vs Peers: S7MB is good value based on its Price-To-Earnings Ratio (16.3x) compared to the peer average (16.8x).
Price to Earnings Ratio vs Industry
How does S7MB's PE Ratio compare vs other companies in the European Commercial Services Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: S7MB is expensive based on its Price-To-Earnings Ratio (16.3x) compared to the European Commercial Services industry average (14.6x).
Price to Earnings Ratio vs Fair Ratio
What is S7MB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 16.3x |
| Fair PE Ratio | 15.1x |
Price-To-Earnings vs Fair Ratio: S7MB is expensive based on its Price-To-Earnings Ratio (16.3x) compared to the estimated Fair Price-To-Earnings Ratio (15.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €11.32 | €11.49 +1.5% | 21.7% | €15.13 | €7.61 | n/a | 12 |
| Nov ’25 | €10.65 | €10.71 +0.6% | 19.8% | €13.95 | €7.67 | n/a | 12 |
| Oct ’25 | €11.37 | €10.83 -4.7% | 21.0% | €14.19 | €7.36 | n/a | 12 |
| Sep ’25 | €10.65 | €10.22 -4.0% | 19.9% | €13.90 | €7.21 | n/a | 11 |
| Aug ’25 | €9.91 | €10.09 +1.9% | 20.8% | €13.81 | €7.17 | n/a | 11 |
| Jul ’25 | €9.33 | €10.11 +8.3% | 20.9% | €14.05 | €7.20 | n/a | 11 |
| Jun ’25 | €9.47 | €9.98 +5.4% | 20.7% | €13.84 | €7.09 | n/a | 11 |
| May ’25 | €9.40 | €9.78 +4.0% | 21.9% | €13.69 | €6.93 | n/a | 11 |
| Apr ’25 | €9.56 | €9.96 +4.3% | 21.9% | €13.83 | €6.48 | n/a | 12 |
| Mar ’25 | €10.12 | €10.10 -0.1% | 22.2% | €14.13 | €6.62 | n/a | 12 |
| Feb ’25 | €8.87 | €9.20 +3.7% | 25.0% | €13.55 | €6.51 | n/a | 12 |
| Jan ’25 | €8.94 | €9.31 +4.1% | 24.5% | €13.71 | €6.63 | n/a | 12 |
| Dec ’24 | €8.32 | €9.02 +8.4% | 24.8% | €13.29 | €6.08 | n/a | 12 |
| Nov ’24 | €7.54 | €9.04 +19.9% | 25.4% | €13.02 | €6.07 | €10.65 | 11 |
| Oct ’24 | €7.21 | €8.94 +24.1% | 25.7% | €13.00 | €6.07 | €11.37 | 11 |
| Sep ’24 | €7.46 | €8.66 +16.0% | 25.7% | €12.60 | €5.88 | €10.65 | 11 |
| Aug ’24 | €7.61 | €8.73 +14.8% | 25.6% | €12.96 | €6.05 | €9.91 | 12 |
| Jul ’24 | €7.43 | €8.49 +14.2% | 25.3% | €12.80 | €5.98 | €9.33 | 12 |
| Jun ’24 | €6.93 | €8.69 +25.4% | 24.6% | €13.18 | €6.15 | €9.47 | 13 |
| May ’24 | €7.96 | €8.75 +9.9% | 24.0% | €13.23 | €6.17 | €9.40 | 14 |
| Apr ’24 | €7.98 | €8.75 +9.7% | 24.0% | €13.27 | €6.19 | €9.56 | 14 |
| Mar ’24 | €8.16 | €8.88 +8.9% | 23.9% | €13.48 | €6.29 | €10.12 | 14 |
| Feb ’24 | €8.37 | €8.67 +3.6% | 24.4% | €13.28 | €6.20 | €8.87 | 14 |
| Jan ’24 | €7.90 | €8.92 +12.9% | 25.1% | €13.75 | €6.42 | €8.94 | 13 |
| Dec ’23 | €7.92 | €8.93 +12.8% | 24.8% | €13.71 | €6.40 | €8.32 | 13 |
| Nov ’23 | €8.30 | €9.28 +11.8% | 28.1% | €16.54 | €6.43 | €7.54 | 12 |
Analyst Forecast: Target price is lower than the current share price.